- Investing Ideas
- /
- Australian Pharmaceuticals & Biotech Financially Fit Penny Stocks
Australian Pharmaceuticals & Biotech Financially Fit Penny Stocks
Results
22
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
22 companies
EZZ Life Science Holdings
Market Cap: AU$104.3m
Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia.
EZZ
AU$2.21
7D
1.4%
1Y
-41.2%
Medical Developments International
Market Cap: AU$74.4m
Manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally.
MVP
AU$0.67
7D
-0.7%
1Y
55.8%
Vita Life Sciences
Market Cap: AU$134.6m
A healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China.
VLS
AU$2.44
7D
-4.7%
1Y
13.0%
Trajan Group Holdings
Market Cap: AU$114.4m
Develops, manufactures, and sells analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India.
TRJ
AU$0.74
7D
0%
1Y
-40.8%
Botanix Pharmaceuticals
Market Cap: AU$274.6m
Operates as a commercial dermatology company in Australia and the United States.
BOT
AU$0.15
7D
20.0%
1Y
-60.5%
Immutep
Market Cap: AU$367.0m
A biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia.
IMM
AU$0.26
7D
2.0%
1Y
-26.1%
Aroa Biosurgery
Market Cap: AU$234.6m
Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.
ARX
AU$0.68
7D
-2.2%
1Y
21.4%
Genetic Signatures
Market Cap: AU$62.5m
Operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas.
GSS
AU$0.27
7D
3.9%
1Y
-60.4%
Avecho Biotechnology
Market Cap: AU$22.2m
A biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, the Americas, and India.
AVE
AU$0.007
7D
0%
1Y
250.0%
Radiopharm Theranostics
Market Cap: AU$68.6m
Engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical needs.
RAD
AU$0.029
7D
-14.7%
1Y
-6.5%
Actinogen Medical
Market Cap: AU$98.4m
A biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia.
ACW
AU$0.031
7D
-8.8%
1Y
24.0%
Invex Therapeutics
Market Cap: AU$12.0m
A biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia.
IXC
AU$0.16
7D
23.1%
1Y
116.2%
Argenica Therapeutics
Market Cap: AU$36.6m
A biotechnology company, engages in the research and development of neuroprotective therapeutic drug in Australia.
AGN
AU$0.27
7D
-6.9%
1Y
-63.5%
Algorae Pharmaceuticals
Market Cap: AU$13.5m
A pharmaceutical development company, engages in the research and development of living cells technologies primarily in New Zealand.
1AI
AU$0.008
7D
14.3%
1Y
14.3%
Dimerix
Market Cap: AU$300.1m
A biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia.
DXB
AU$0.52
7D
-2.8%
1Y
33.3%
Race Oncology
Market Cap: AU$587.5m
A clinical stage biopharmaceutical company, focuses on addressing the unmet needs of cancer patients for damaging treatments.
RAC
AU$3.11
7D
21.0%
1Y
71.3%
Tissue Repair
Market Cap: AU$17.5m
A clinical stage biopharmaceutical company, develops advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia.
TRP
AU$0.28
7D
0%
1Y
-23.6%
Hexima
Market Cap: AU$2.2m
Does not have significant operations.
HXL
AU$0.013
7D
0%
1Y
-18.8%
BCAL Diagnostics
Market Cap: AU$24.9m
A screening and diagnostic company, engages in developing a novel blood screening test to improve the diagnosis and monitoring of breast cancer.
BDX
AU$0.07
7D
1.4%
1Y
-44.0%
Neurizon Therapeutics
Market Cap: AU$68.9m
A clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases.
NUZ
AU$0.13
7D
-10.3%
1Y
-35.0%
Starpharma Holdings
Market Cap: AU$92.0m
A biopharmaceutical company, engages in the research, development and commercialization of dendrimer technology for pharmaceutical, healthcare applications, life science, and other applications internationally.
SPL
AU$0.23
7D
84.0%
1Y
132.3%
Cleo Diagnostics
Market Cap: AU$50.1m
A biotechnology company, focuses on the development and commercializing of non-invasive blood tests to detect ovarian cancer in Australia.
COV
AU$0.37
7D
-11.9%
1Y
-3.9%